Back
Jasper Therapeutics Stock Predictions
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
49
JSPR
Jasper Therapeutics
Last Price:
$5.56
Seasonality Move:
-11.28%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaJasper Therapeutics Stock Forecast
-
Over the next 52 weeks, Jasper Therapeutics has on average historically fallen by 24.2% based on the past 5 years of stock performance.
-
Jasper Therapeutics has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Jasper Therapeutics Stock Undervalued?The current Jasper Therapeutics [JSPR] share price is $5.57. The Score for JSPR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
JSPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Jasper Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Jasper Therapeutics has on average historically fallen by 24.2% based on the past 5 years of stock performance.
Jasper Therapeutics Stock Rating
Sell
49
Jasper Therapeutics (JSPR)
is a Sell
Is Jasper Therapeutics overpriced?
-
Jasper Therapeutics has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Jasper Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
jaspertherapeutics.com
52-Week Data
52-Week High:
26.05
52-Week Low:
3.13
Prediction Charts
Market Cap:
83.6M
Price in USD:
5.57
Volume:
223.2K
Beta:
2.13
Technical Analysis
SMA50:
0.00
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
-73.87%
Stock Predictions
-
Is Jasper Therapeutics stock public?Yes, Jasper Therapeutics is a publicly traded company.
-
What is the Jasper Therapeutics stock quote today?The Jasper Therapeutics stock price is 5.57 USD today.
-
How to buy Jasper Therapeutics stock online?You can buy Jasper Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-5 | 6.00 | 5.70 | 6.03 | 5.56 |
| Jun-6 | 5.84 | 6.01 | 6.02 | 5.67 |
| Jun-9 | 6.05 | 5.94 | 6.10 | 5.86 |
| Jun-10 | 5.94 | 5.77 | 6.13 | 5.65 |
| Jun-11 | 5.85 | 5.60 | 5.94 | 5.55 |
| Jun-12 | 5.56 | 5.57 | 5.63 | 5.40 |
| Jun-13 | 5.50 | 5.58 | 5.65 | 5.43 |
| Jun-16 | 6.00 | 5.63 | 6.00 | 5.46 |
| Jun-17 | 5.61 | 5.41 | 5.80 | 5.41 |
| Jun-18 | 5.41 | 5.26 | 5.51 | 5.23 |
| Jun-20 | 5.30 | 5.15 | 5.48 | 5.01 |
| Jun-23 | 5.13 | 5.13 | 5.59 | 4.76 |
| Jun-24 | 5.15 | 5.57 | 5.72 | 5.06 |
| Jun-25 | 5.58 | 5.57 | 5.59 | 5.12 |
Jasper Therapeutics Earnings
Jasper Therapeutics Earnings Report: Per Share Jasper Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Jasper Therapeutics Forecast Revenue Growth
Jasper Therapeutics Stock Analysis: Historical quarterly revenues per share for Jasper Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.02 per share.
* Jasper Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.